Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Colorado MEDtech, CMED -- Ignore unavailable to you. Want to Upgrade?

To: Ryan Plovie (Hijacked) who wrote (82)	3/18/1998 2:16:00 PM
From: WallStBum	Respond to of 288

CMED was profiled by MicroCapitalist Research MCRR mcrr.com at 2 7/8 in Feb 97. I think M.H. Meryerson also follows them and rec'd after MCRR did. John G. Kinnard picked them up a few months back, they are covered according to First Call by 1 broker - First Call shows CMED as a 1 (1 = strong buy). Also see my previous posts on this board discussing above. When it seems as though CMED stalled at $10, remember CMED started 1998 in the $6 dollar range and I'm certain a 50% gain in 2-3 months was worth a bit of mild profit-taking. I'd say CMED resilience coming off 8 1/4 now almost $9 today speaks of their potential and the market's recognition of a real story here. I'm looking to the low teens next. dax dax